Study to Evaluate Satisfaction and Usability of DuoResp® SPIROMAX® in Asthma and COPD Treatment

Clinical trial NCT02384577 · COMPLETED

Trial details

NCT number: NCT02384577
Sponsor: Teva Pharma GmbH
Status: COMPLETED
Study type: OBSERVATIONAL

Patient Satisfaction

Start date: 2014-07-01
Primary completion: 2016-03-01
Enrollment: 4034

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.